Local Oncologist Releases New Research at National Oncology Meeting
Fayetteville, AR, July 7, 2014 (Newswire.com) - Dr. J. Thaddeus Beck, M.D., F.A.C.P. of Highlands Oncology Group (HOG), recently attended the 50th annual American Society of Clinical Oncology (ASCO) meeting, held in Chicago, where he released new abstracts on cancer research and treatment.
An annual ASCO meeting is held where oncologists from around the country meet to discuss breakthroughs or changes in medical oncology treatment and awareness, to present lectures and presentations and to provide educational experiences on focused topics in clinical oncology.
Dr. Beck presented findings on different treatment trials ranging from kidney cancer treatment to pancreatic cancer treatment.
The ASCO Annual Meeting brings together more than 25,000 oncology professionals from a broad range of specialties, according to the ASCO website
The annual ASCO meeting was held from May 30 to June 3.
As the leading cancer treatment and research facility in Northwest Arkansas, HOG is dedicated to the advancement of cancer treatment and to provide patients with the best possible care and results.
###
Highlands Oncology Group is a state-of-the-art facility, with a world-class team of specialists, that is committed to providing premier cancer treatment and to enhancing the quality of life of patients and their loved ones. Highlands Oncology group provides this in a friendly, comfortable environment conveniently located in Northwest Arkansas. Highlands offers the latest technology of diagnostic imaging and radiation therapies, on-site labs, a pharmacy and an infusion center. They also offer access to clinical trials, multidisciplinary clinics and support groups. Highlands Oncology Group is helping patients win the battle against cancer every day.
Visit highlandsoncologygroup.com
